Retevmo™ (selpercatinib) capsules

40 mg, 80 mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

RETEVMO™ (selpercatinib): Patient Copay Assistance

Assistance is available to qualified patients in paying for their medication.

Savings Card

For information about Retevmo Ongoing Support and financial assistance for eligible patients, including co-pay assistance, please call the Lilly Oncology Support Center at 1-866-472-8663 , Monday through Friday, 8 AM to 10 PM ET.

Date of Last Review: May 14, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 8am - 7pm ET

Or you can

Ask us a question Chat with us

Submit a Request

Visit Us @LillyMedical